Scribe’s CRISPR-based cholesterol reduction therapy is part of a three-pronged approach to combating cardiovascular disease. Genetic medicine biotech Scribe Therapeutics…
New research suggests Junevity’s siRNA approach could reverse age-related cellular decline without triggering dedifferentiation or cancer-related pathways. A new paper…
